Table 1. Baseline characteristics.
| Characteristic | Cases n=73 (31%) |
Controls, n=157 (69%) |
|---|---|---|
| Male gender, n (%) | 30 (41.10) | 40 (25.48) |
|
| ||
| Age at ART initiation, median (IQR) | 36 (32 - 43) | 33 (28 - 38) |
|
| ||
| Smoking Status | ||
|
| ||
| Never | 53 (72.60) | 119 (75.80) |
| Past or current | 18 (26.14) | 36 (22.93) |
|
| ||
| BMI (Kg/m2) categories, n (%) | ||
|
| ||
| < 25 | 50 (68.49) | 128 (81.53) |
| 25 - 29.9 | 15 (20.55) | 17 (10.83) |
| ≥ 30 | 4 (5.48) | 2 (1.27) |
| Missing | 4 (5.48) | 10 (6.37) |
|
| ||
| CD4+ T cell counts (cells/mm3) at ART initiation, n (%) | ||
|
| ||
| < 100 | 29 (39.73) | 48 (30.57) |
| 100 – 249 | 35 (47.95) | 82 (52.23) |
| ≥ 250 | 9 (12.33) | 27 (17.20) |
| Missing | 1 (1.37) | 4 (2.55) |
|
| ||
| HIV viral load (Log10/mm3), median (IQR) | 5.09 (4.72 - 5.63) | 5.07 (4.60 - 5.50) |
|
| ||
| Duration of observation until censor (years), median (IQR) | 7.29 (6.37 - 7.87) | 5.76 (1.59 - 7.14) |
|
| ||
| Clinic visits with blood pressure measurement during observation, median (IQR) | 35 (29 - 38) | 27 (13 - 36) |
BMI: Body mass index; ART: Antiretroviral therapy; CD4: cluster differentiation cells; IQR: interquartile range